baber/WOPTO huggingface dataset:
Patent AU-2018285710-A1 (AU)
Title: Methods and compositions for treating cancer
Inventor: BECKER LEV
IPC: A61P35/00
Filed: 2018-06-15
Abstract: Embodiments are directed to: (i) neutrophil secreted factors that have the capacity to kill a broad range of cancer cells without affecting the viability of non-cancer cells. Two neutrophil killing factors have been identified by the inventors: (1) eosinophil cationic protein (ECP) and (2) neutrophil elastase (ELANE); or (ii) therapeutic compositions that include CD95 degrading polypeptide components and methods of treating cancer with the same.
Patent AU-2018318073-A1 (AU)
Title: Gas-fed fermentation reactors, systems and processes utilizing gas/liquid separation vessels
Inventor: NGUYEN LUAN THANH
IPC: B01D19/00
Filed: 2018-08-13
Abstract: Reactors, systems and processes for the production of biomass by culturing microorganisms in aqueous liquid culture medium circulating inner loop reactor which utilize nonvertical pressure reduction zones are described. Recovery and processing of the culture microorganisms to obtain products, such as proteins or hydrocarbons is described.
Patent AU-2018357176-A1 (AU)
Title: Biodegradable polyester and use thereof
Inventor: WANG WEIWEI
IPC: C08G63/183
Filed: 2018-06-26
Abstract: The present invention involves a biodegradable polyester and the use thereof, said biodegradable polyester comprising: A) an acid component comprising the following repeating units: 50-58mol% of terephthalic acid A1; 30-40mol% of sebacic acid A2; and 2-20 mol% of aliphatic dibasic acid A3 having a carbon chain length with less than or equal to 6; and B) a butanediol. According to the present invention, the material toughness can be improved by introducing the aliphatic dibasic acid monomer having a carbon chain length with less than or equal to 6 carbons when it shows a high content of terephthalic acid, and by using the biodegradable polyester obtained when it meets the degradation capacity and rigidity requirements.
Patent AU-2018380409-A1 (AU)
Title: Tryptophan derivatives as sweeteners
Inventor: JIANG DESHOU
IPC: C07D209/20
Filed: 2018-12-07
Abstract: The present disclosure provides compounds of Formula (I) and edible compositions comprising compounds of Formula (I) which are suitable for use as sweeteners, for example, by incorporation into edible compositions. Also provided herein are methods of preparing comestible compositions comprising compounds of Formula (I).
Patent AU-2018390293-A1 (AU)
Title: Systems and methods for filtering social media interactions and online content based on personal genetic profiles
Inventor: SMITH ROBIN Y
IPC: G06Q50/00
Filed: 2018-05-31
Abstract: Presented herein are systems and methods for automatically managing and filtering social media interactions and/or online content based on genetic profiles of users. These genetic profiles include identifications of genetic interests of the users and/or genetic information to which they have permitted access. Such permissioned personal genetic profiles may be used to facilitate, manage, and filter a variety of online interactions between the user and other members of various services and/or online content in order to lead to meaningful and successful real world interactions and/or to improve the relevance of online content delivered to a user.
Patent AU-2018408382-A1 (AU)
Title: Nanoparticles of encapsulated light-absorbing agent, preparation thereof and ophthalmic lens comprising said nanoparticles
Inventor: FROMENTIN PIERRE
IPC: G02B5/20
Filed: 2018-02-09
Abstract: The invention relates to nanoparticles of a composite material comprising a light absorbing agent dispersed in a matrix of a mineral oxide, to a method for the preparation of such nanoparticles, to the use of said method to modify the hue of nanoparticles of composite material comprising a light absorbing agent, and to an ophthalmic lens comprising such nanoparticles.
Patent AU-2018415814-A1 (AU)
Title: Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy
Inventor: WARDELL SETH
IPC: A61K35/17
Filed: 2018-06-29
Abstract: The present invention provides improved and/or shortened methods for expanding TILs and producing therapeutic populations of TILs, including novel methods for expanding TIL populations in a closed system that lead to improved efficacy, improved phenotype, and increased metabolic health of the TILs in a shorter time period, while allowing for reduced microbial contamination as well as decreased costs. Such TILs find use in therapeutic treatment regimens.
Patent AU-2018432845-A1 (AU)
Title: Salting out inhibitors for use in treatment fluids
Inventor: ELURU SAIRAM
IPC: C09K8/575
Filed: 2018-07-18
Abstract: Methods and system for using salting out inhibitors in subterranean formations are provided. In some embodiments, the methods comprise introducing a treatment fluid comprising an aqueous base fluid, a salting out inhibitor, a gelling agent, and one or more salts into at least a portion of a subterranean formation, wherein the salting out inhibitor is selected from the group consisting of: an oligomer comprising one or more quaternary ammonium cations, a polymer comprising one or more quaternary ammonium cations, a source of one or more phosphate anions, and any combination thereof.
Patent WO-2019195890-A1 (WO)
Title: Formulations and kits for radiotherapy and diagnostic imaging
Inventor: HARRIS MATTHEW JOHN
IPC: A61K51/04
Filed: 2019-04-11
Abstract: Aqueous formulations and kits of radiopharmaceutical compounds of general Formula (II) protected from radiolysis with stabilisers, such as L-methionine and gentisic acid, are disclosed, wherein the compounds are based on sarcophagine ligands coordinated to a radioisotope, such as 64-copper, and linked to a tetrazine group for reaction with tumour targeting antibodies having functional reactive groups such as trans-cyclooctene, processes of preparing said radioligand formulations, and uses thereof for radioimaging, diagnosing and treating cancer.
Patent WO-2020093095-A1 (WO)
Title: "a chromatography component"
Inventor: SHALLIKER ANDREW ROSS
IPC: B01D15/08
Filed: 2019-11-07
Abstract: A chromatography column fitting (30) includes a body member (40) configured to be received at an end of a chromatography column (18), the body member (40) defining an axially extending open bore (42). An insert (44) is received in the bore (42), the insert (44) defining a flow conduit (46) opening out into an operatively inner end (50) of the insert (44) to be in flow communication, in use, with an interior (34) of the chromatography column (18), the operatively inner end (50) defining a bearing surface (52). The bearing surface (52) bears against contents (36, 38) at the end of the chromatography column (18) to minimise dead volume between the flow conduit (46) and the contents (36, 38) of the chromatography column (18).
Patent AU-2019201522-A1 (AU)
Title: Intra-aortic balloon apparatus, assist devices and methods for improving flow, counterpulsation and haemodynamics
Inventor: ANAGNOSTOPOULOS CONSTANTINOS
IPC: A61M60/865
Filed: 2019-03-05
Abstract: INTRA-AORTIC BALLOON APPARATUS, ASSIST DEVICES AND METHODS FOR IMPROVING FLOW, COUNTERPULSATION AND HAEMODYNAMICS A circulatory assist apparatus comprising: an inflatable pumping balloon (1.1) having a proximal end joined to an elongated balloon catheter (1.20), the balloon catheter (1.20) having a distal end joined to the pumping balloon (1.1) and a proximal end, separated from the distal end by a length sufficient to extend from within a circulatory lumen to the outside of a patient's body, for receiving positive and negative pressure pulses from a pump to inflate and deflate the pumping balloon (1.1); and a radially expandable frame (1.3), mounted on one of a segment extending distally from the pumping balloon (1.1), the balloon catheter (1.20), and a sleeve tube (1.87) surrounding the balloon catheter (1.20). The expandable frame (1.3) is manipulable to expand within the circulatory lumen, and functions to space apart the inflatable pumping balloon from the circulatory lumen, having a first diameter in a collapsed configuration for intraluminal delivery and a second, larger diameter in an expanded configuration achieved by said manipulation
Patent AU-2019215231-A1 (AU)
Title: Pharmaceutical compositions for treating cystic fibrosis
Inventor: CHU CATHY
IPC: A61K31/443
Filed: 2019-02-04
Abstract: A pharmaceutical composition comprising Compound (I). Methods of treating cystic fibrosis comprising administering one or more of such pharmaceutial compositions to a patient.
Patent AU-2019222874-A1 (AU)
Title: Antibodies against claudin 18.2 useful in cancer diagnosis
Inventor: SAHIN UGUR
IPC: C07K16/30
Filed: 2019-08-28
Abstract: Abstract The invention relates to antibodies directed against an epitope located within the C-terminal portion of CLDN18.2 which are useful, for example, in diagnosing 5 cancer and/or in determining whether cancer cells express CLDN18.2.
Patent AU-2019223083-A1 (AU)
Title: Light emitting apparatus with melanopic emission spectrum
Inventor: SOLER ROBERT
IPC: H01L33/58
Filed: 2019-02-22
Abstract: A light emitting diode (LED) with a melanopic emission spectrum can comprise a primary light source and a phosphor. The primary light source can comprise an emission spectrum comprising a first peak centered at a wavelength from 480 nm to 500 nm. The phosphor, when excited, can comprise an emission spectrum with a second peak centered at a wavelength from 640 nm to 750 nm, and the intensity of the first peak is greater than the intensity of the second peak. A light emitting apparatus can comprise a first LED with a traditional white light emission spectrum, and a second LED with a melanopic emission spectrum. The light emitted from the apparatus can comprise chromaticity coordinates, in the CIE 1931 color space diagram using the 1964 10° Supplementary Standard Observer, that are within a one-step MacAdam ellipse from the black body locus with chromaticity coordinate x from 0.34 to 0.45.
Patent AU-2019225946-A1 (AU)
Title: Shaped detergent product comprising aminopolycarboxylate
Inventor: ARLABOSSE HÉLÈNE JULIE MARIE
IPC: C11D17/00
Filed: 2019-02-12
Abstract: A shaped detergent product comprising 10 to 100 wt. % of a first solid phase and 0 to 90 wt. % of one or more other phases, said first solid phase comprising: a) non-crystalline chiral aminopolycarboxylate; b) non-crystalline organic acid other than component a); c) at most 30 wt. % water; d) at most 50 wt. % of non-crystalline water-soluble component other than component a) or component b); e) at most 20 wt. % of homogeneously dispersed crystalline material; wherein the combination of the components a), b) and c) is present in the first solid phase in a concentration of at least 35 wt. % of the total weight of said solid phase; and wherein components a), b) and c) are present in the solid phase in a ratio of from 25 to 88 parts by weight of free acid equivalent of component a) : from 10 to 60 parts by weight of free acid equivalent of component b) : from 2 to 30 parts by weight of component c); and wherein the shaped detergent product comprises at least 0.5 wt. % surfactant.
Patent AU-2019264159-A1 (AU)
Title: Polyunsaturated fatty acid monoglycerides, compositions, methods and uses thereof
Inventor: FORTIN SAMUEL C
IPC: A61P1/00
Filed: 2019-05-03
Abstract: There are provided various compounds and compositions comprising polyunsaturated fatty acid monoglycerides and derivatives thereof. These compounds and compositions can be useful for use as prebiotic in a subject; for the modulation of the microbiota composition; for enhancing the population of good bacteria like
Patent AU-2019272450-A1 (AU)
Title: Systems for aseptic urine sampling and methods thereof
Inventor: WAITKUS TIM
IPC: A61M39/10
Filed: 2019-05-13
Abstract: A urine-sampling system for aseptic urine sampling includes a catheter assembly and a sampling-port access device. The catheter assembly includes a urinary catheter, drainage tubing, and a connector fluidly connecting the urinary catheter to the drainage tubing. The connector includes a urine-sampling port. The sampling-port access device includes a tip at an end of a barrel configured to fluidly connect the sampling-port access device to the urine-sampling port of the catheter assembly. Each of the tip of the sampling-port access device and the urine-sampling port has a complementary fastening means for- fastening to the other of the tip of the sampling-port access device and the urine-sampling port. Each of the complementary fastening means ensures proper mating of the tip of the sampling-port access device and the urine-sampling port for aseptic urine sampling. In addition to various urine-sampling systems such as the foregoing, methods of use are also disclosed.
Patent AU-2019280020-A1 (AU)
Title: High osmolarity antimicrobial composition containing one or more organic solvents
Inventor: MYNTTI MATTHEW F
IPC: A01N37/02
Filed: 2019-12-12
Abstract: A liquid wound wash composition adapted for dermal application, said composition consisting of (1) a solvent component exhibiting a 6p value of from 13.7 to 15.4 MPa 112 that consists of water and ethanol; and (2) a solute component that consists of cationic surfactant, dissociation products of at least one polyacid and dissociation products of at least one salt of at least polyacid, said composition having a pH of greater than about 3 but less than 4.4 and an effective solute concentration of from 1 to 2.33 Osm/L. 4 pH with DGME -a-4 pH with IPA -.*--10 pH with DGME -0-10 pH with IPA 0.0 I z 0 1000 2000 3000 osmolarity(mosm) 100%. 90% 80% 70% 60% 01 50% U 40% IL 30% 0 20% 10% 0% 13.5 14.0 14.5 15.0 15.5 Polarity Parameter -4- 8.8pH Solutions -0-10 pH Solutions
Patent AU-2019282327-A1 (AU)
Title: Dosing and effect of C5A antagonist with ANCA-associated vasculitis
Inventor: DENG JUN
IPC: A61K31/445
Filed: 2019-06-06
Abstract: The present disclosure provides methods for treating ANCA-associate vasculitis in a human in need thereof, the method comprising administering to the human a therapeutically effective amount of avacopan: or a pharmaceutically acceptable salt thereof, such that the level of plasma complement factor Bb, C3a, or C5a does not significantly change in the human upon treatment.
Patent AU-2019290529-A1 (AU)
Title: Burner panel for a metallurgical furnace
Inventor: FERGUSON SCOTT A
IPC: F27B13/12
Filed: 2019-06-17
Abstract: One or more embodiments of a burner panel for a metallurgical furnace is described herein. One or more embodiments of a burner panel for a metallurgical furnace are described herein. The sidewall burner pockets have a burner panel therein. The burner panel has a body having an interior face with burner tube disposed therethrough. The burner tube has a first portion and a second portion coupled to the first portion. The burner panel additionally has an internal mounting flange extending along the periphery of the body and overlapping the sidewall, the sidewall and internal mounting flange compressed together by a coupling.
Patent AU-2019290636-A1 (AU)
Title: Transportation security
Inventor: KAIR LEE
IPC: G06K9/66
Filed: 2019-06-19
Abstract: In a transportation security technique, images are stored that are received from image capturing equipment deployed at respective screening nodes. The images are analyzed using a machine learning model, where presence of a particular object in an image indicates that a threat condition exists at the screening node. The analyzed images are transmitted to threat assessment components in accordance with predetermined criteria. An indication that the particular object is observed in the image is received from the threat assessment components. An indication that the particular object is observed in the image is transmitted to the screening node responsive to receiving the indication that the particular object is observed in the image. An indication of whether the particular object is present at the screening node is received. The machine learning model is trained based on the received indication of whether the particular object is observed in the image.
Patent AU-2019294284-A1 (AU)
Title: Compositions comprising bacterial strains
Inventor: YUILLE SAMANTHA
IPC: A61P43/00
Filed: 2019-06-25
Abstract: The invention provides compositions comprising bacterial strains for use in therapy.
Patent AU-2019298069-A1 (AU)
Title: Method and arrangement for managing power consumption in a mine
Inventor: LINDKVIST ANDERS
IPC: H02J3/32
Filed: 2019-07-03
Abstract: The present invention relates to a method and arrangement for managing power consumption in one or more local power grids comprised in corresponding parts of a mine environment, the one or more local power grids connected to a main power grid. The method comprises obtaining information regarding expected power consumption of direct loads during a predetermined cycle of operation in the one or more local power grids, wherein the direct loads comprise one or more mining consumers connected to the one or more local power grids and obtaining information regarding expected power consumption of indirect loads when connected to the one or more local power grids, wherein the indirect loads comprise one or more batteries for use in respective battery operated mining machines. The method further comprises predicting one or more time periods of high or low power consumption during the predetermined cycle of operation, wherein high power consumption corresponds to a power consumption above a predetermined peak power consumption indicating threshold and low power consumptioncorresponds to a power consumption below a predetermined surplus power indicating threshold. Power utilization is scheduled forthe one or more local power grids and connected indirect loads during the predicted one or more time periods.
Patent AU-2019304101-A1 (AU)
Title: Active damping system
Inventor: PIVAC MARK JOSEPH
IPC: B25J19/00
Filed: 2019-07-16
Abstract: The present disclosure provides a system for performing interactions within a physical environment, the system including: (a) a robot base; (b) a robot base actuator that moves the robot base relative to the environment; (c) a robot arm mounted to the robot base, the robot arm including an end effector mounted thereon; (d) a tracking system that measures at least one of: (i) a robot base position indicative of a position of the robot base relative to the environment; and, (ii) a robot base movement indicative of a movement of the robot base relative to the environment; (e) an active damping system that actively damps movement of the robot base relative to the environment; and, (f) a control system that: (i) determines a movement correction in accordance with signals from the tracking system; and, (ii) controls the active damping system at least partially in accordance with the movement correction.
Patent AU-2019358201-A1 (AU)
Title: Method of making releasable polymeric reagents
Inventor: CULBERTSON SEAN M
IPC: C08G65/333
Filed: 2019-10-11
Abstract: The instant disclosure provides (among other things) improved methods of preparing fluorenyl-based polymeric reagents, methods of recovering and purifying such polymeric reagents, methods of reducing unwanted impurities in a fluorenyl-based polymeric reagent, fluorenyl-based polymeric reagents prepared by the methods described herein, and conjugates prepared by reaction with fluorenyl-based polymeric reagents prepared by the methods described herein.
Patent AU-2019377515-A1 (AU)
Title: Treatment for giant cell arteritis
Inventor: PAOLINI JOHN
IPC: A61P9/10
Filed: 2019-11-07
Abstract: The present invention provides, among other things, methods of treating giant cell arteritis, comprising a step of administering to a subject in need of treatment a GM-CSF antagonist (e.g., an anti-GM-CSFRα antibody or an anti-GM-CSF antibody) at a therapeutically effective dose and an administration interval for a treatment period sufficient to improve, stabilize or reduce one or more symptoms of giant cell arteritis relative to a control.
Patent AU-2019377868-A1 (AU)
Title: Fluid exchange devices and related controls, systems, and methods
Inventor: JUDGE SCOTT
IPC: F04F13/00
Filed: 2019-11-08
Abstract: Pressure exchange devices, systems, and related methods may include a tank, a piston, a valve device, and one or more sensors for monitoring a position of the piston in the tank.
Patent AU-2019388551-A1 (AU)
Title: Legged robot
Inventor: KENNEALLY GAVIN
IPC: B62D57/032
Filed: 2019-09-26
Abstract: A legged robot having a frame with a plurality of links in mechanical communication with plurality of brackets, the frame forming a front, back, top, bottom, and sides, legs in mechanical communication with one or more of the plurality of brackets, each leg having a knee motor, an abduction motor, and a hip motor, a computer module in mechanical communication with one or more of the plurality of brackets and in electrical communication with the legs, and a power module in mechanical communication with one or more of the plurality of brackets and in electrical communication with the legs and the computer module.
Patent AU-2019392651-A1 (AU)
Title: Modular grill and burn barrel
Inventor: BURCH II ROBERT L
IPC: A47J37/07
Filed: 2019-12-04
Abstract: A container suitable for capturing fire, said container comprising an outer housing having an open top and a closed bottom, an inner fire-containing receptacle fitting within the outer housing, a grate, and means to raise or lower one of the grate or fire-containing receptacle, said container comprising a lid fashioned to engage with the open top of the outer housing, and a tripod stand capable of suspending the container and comprising a lift system engaged to said lid to operate the lid from a position engaged with the open top to a position disengaged with the open top.
Patent AU-2019478841-A1 (AU)
Title: Methods for identifying a companion animal at risk of calcium oxalate stone formation and treatments and compositions for reducing the risk
Inventor: JEWELL DENNIS
IPC: A23K50/40
Filed: 2019-12-18
Abstract: Methods of analyzing a biological sample obtained from the feline subject for the presence of one or two copies of minor allele A of SNP A1_212891692 and/or to the concentration of beta-amino isobutyrate and/or 2-oxoarginine concentrations in the sample are disclosed. The methods are used in methods to identify a feline subject that has an increased likelihood or risk of calcium oxalate stone formation and in methods of treating a feline subject to reduce risk of calcium oxalate stone formation. The treatment on comprises administering to the feline subject a low arginine diet. Low arginine feline food compositions are disclosed.
Patent WO-2021062483-A1 (WO)
Inventor: STRANGE WARREN
IPC: E21B4/16
Filed: 2020-10-02
Abstract: A liquid hammer drill comprising: a housing; a drill bit at a leading end of said housing wherein said drill bit includes a trailing end and a leading end that defines a cutting portion; a piston member located inside said housing and having a trailing end, a leading end and an intermediate portion therebetween, said piston member being capable of movement between a first position and a second position at which it impacts the trailing end of the drill bit; a liquid circuit for delivering a liquid to the piston member to cause the piston member to oscillate between its first and second positions and transfer the liquid outside the housing via a liquid outlet; a sealing member for isolating the trailing end of the drill bit from the liquid circuit wherein, in use, the piston member impacts the trailing end of the drill bit in a liquid free environment.
Patent WO-2021077176-A1 (WO)
Inventor: LINDLEY ROBYN
IPC: C12Q1/6883
Filed: 2020-10-26
Abstract: This invention relates generally to systems and methods for diagnosing a neurodegenerative disorder in a subject. In particular embodiments, the methods of the disclosure can be used to for the diagnosis of Mild Cognitive Impairment (MCI), Early Mild Cognitive Impairment (EMCI), Late Mild Cognitive Impairment (LMCI), Parkinson's Disease (PD), Dementia or Alzheimer's Disease. In other embodiments, the methods involve treatment of a subject diagnosed with such diseases.